rhHNS

recombinant human iduronidase? (Note: rhHNS refers to a recombinant human heparan/N-sulfoglucosaminidase surrogate; if specific generic name is not provided, set as null) · Shire

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for rhHNS, covering 2017-03-03 to 2020-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Extension of Study HGT-SAN-055 Evaluating Administration of rhHNS in Patients With Sanfilippo Syndrome Type A (MPS IIIA) [Phase 1, Phase 2]

See pricing